254 related articles for article (PubMed ID: 30275445)
1. Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.
Tome-Garcia J; Erfani P; Nudelman G; Tsankov AM; Katsyv I; Tejero R; Bin Zhang ; Walsh M; Friedel RH; Zaslavsky E; Tsankova NM
Nat Commun; 2018 Oct; 9(1):4020. PubMed ID: 30275445
[TBL] [Abstract][Full Text] [Related]
2. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
[TBL] [Abstract][Full Text] [Related]
3. Role of aquaporin-4 in the regulation of migration and invasion of human glioma cells.
Ding T; Ma Y; Li W; Liu X; Ying G; Fu L; Gu F
Int J Oncol; 2011 Jun; 38(6):1521-31. PubMed ID: 21424125
[TBL] [Abstract][Full Text] [Related]
4. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
5. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract][Full Text] [Related]
6. TEAD1 enhances proliferation via activating SP1 in colorectal cancer.
Yu MH; Zhang W
Biomed Pharmacother; 2016 Oct; 83():496-501. PubMed ID: 27434865
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
8. TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo.
Joshi S; Davidson G; Le Gras S; Watanabe S; Braun T; Mengus G; Davidson I
PLoS Genet; 2017 Feb; 13(2):e1006600. PubMed ID: 28178271
[TBL] [Abstract][Full Text] [Related]
9. miR‑454‑3p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma.
Hui X; Zhang S; Wang Y
Mol Med Rep; 2018 Oct; 18(4):3965-3972. PubMed ID: 30106109
[TBL] [Abstract][Full Text] [Related]
10. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.
Schuster A; Klein E; Neirinckx V; Knudsen AM; Fabian C; Hau AC; Dieterle M; Oudin A; Nazarov PV; Golebiewska A; Muller A; Perez-Hernandez D; Rodius S; Dittmar G; Bjerkvig R; Herold-Mende C; Klink B; Kristensen BW; Niclou SP
Nat Commun; 2020 Dec; 11(1):6366. PubMed ID: 33311477
[TBL] [Abstract][Full Text] [Related]
11. YTHDF1-regulated expression of TEAD1 contributes to the maintenance of intestinal stem cells.
Jiang D; Hou J; Qian Y; Gao Y; Gao X; Wei S
Biochem Biophys Res Commun; 2021 Jun; 557():85-89. PubMed ID: 33862464
[TBL] [Abstract][Full Text] [Related]
12. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
13. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
14. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
15. Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.
Huang YC; Lai JC; Peng PH; Wei KC; Wu KJ
Clin Epigenetics; 2021 Nov; 13(1):201. PubMed ID: 34732244
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.
Godlewski J; Ferrer-Luna R; Rooj AK; Mineo M; Ricklefs F; Takeda YS; Nowicki MO; Salińska E; Nakano I; Lee H; Weissleder R; Beroukhim R; Chiocca EA; Bronisz A
Stem Cell Reports; 2017 Jun; 8(6):1497-1505. PubMed ID: 28528698
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
[TBL] [Abstract][Full Text] [Related]
18. High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.
Hucl T; Brody JR; Gallmeier E; Iacobuzio-Donahue CA; Farrance IK; Kern SE
Cancer Res; 2007 Oct; 67(19):9055-65. PubMed ID: 17909009
[TBL] [Abstract][Full Text] [Related]
19. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
20. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.
Galavotti S; Bartesaghi S; Faccenda D; Shaked-Rabi M; Sanzone S; McEvoy A; Dinsdale D; Condorelli F; Brandner S; Campanella M; Grose R; Jones C; Salomoni P
Oncogene; 2013 Feb; 32(6):699-712. PubMed ID: 22525272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
